Clinical Trials Logo

Clinical Trial Summary

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.


Clinical Trial Description

The Genetics of Appendix Cancer (GAP) Study aims to analyze hereditary factors, tumor characteristics and clinical features/outcomes among adults diagnosed with appendix cancer and their biological parents. Patients are recruited at any time after a diagnosis of appendix cancer and followed for up to 6 years after study enrollment. This cohort is enriched by robust biospecimens and data collections. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05734430
Study type Observational
Source Vanderbilt-Ingram Cancer Center
Contact GAP Study Coordinator (Rebecca B.)
Phone 615-936-8544
Email gapcancerstudy@vumc.org
Status Recruiting
Phase
Start date November 11, 2022
Completion date November 2034

See also
  Status Clinical Trial Phase
Recruiting NCT05623787 - Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms N/A
Active, not recruiting NCT05305820 - Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy N/A
Recruiting NCT04907643 - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes N/A
Completed NCT04526886 - Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy N/A
Recruiting NCT06216561 - Intraperitoneal LSTA1 in CRS-HIPEC Phase 1
Recruiting NCT05277766 - Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer Phase 1
Terminated NCT03287947 - LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma Phase 2
Recruiting NCT04028479 - The Registry of Oncology Outcomes Associated With Testing and Treatment
Active, not recruiting NCT04902872 - Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors Phase 1/Phase 2
Recruiting NCT05919758 - Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix
Active, not recruiting NCT01815359 - ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis Phase 2
Not yet recruiting NCT06263088 - EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. N/A
Completed NCT02833753 - Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI Phase 1
Recruiting NCT05780684 - Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer N/A
Recruiting NCT03210298 - International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
Not yet recruiting NCT04634448 - The Prevalence of Appendiceal Tumours in Periappendicular Abscess N/A
Active, not recruiting NCT04157322 - Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis
Completed NCT02489422 - Programs To Support You During Chemotherapy N/A